Patricia Udaondo, MD, PhD and Ramin Tadayoni, MD, PhD
Show Description +
What does a new study of baseline characteristics tell us about DME patients' response to the intravitreal dexamethasone implant 0.7 mg (Ozurdex, Allergan)? Patricia Udaondo, MD, PhD, explores the findings of her paper with Clinical Minute: Retina host Ramin Tadayoni, MD, PhD. They examine the study's conclusions, ask how these findings affect clinical decision-making, and assess whether external factors such as phakic status influence drug choice.
Posted: 10/09/2023
Patricia Udaondo, MD, PhD and Ramin Tadayoni, MD, PhD
What does a new study of baseline characteristics tell us about DME patients' response to the intravitreal dexamethasone implant 0.7 mg (Ozurdex, Allergan)? Patricia Udaondo, MD, PhD, explores the findings of her paper with Clinical Minute: Retina host Ramin Tadayoni, MD, PhD. They examine the study's conclusions, ask how these findings affect clinical decision-making, and assess whether external factors such as phakic status influence drug choice.
Posted: 10/09/2023
Please log in to leave a comment.